Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H46N4O7 |
InChIKeyUHNYITHLNFUAIN-ZMELPTPBSA-N |
CAS Registry1620107-36-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | 15 Jul 2014 |